Cargando…
Evaluation of the antitumor mechanism of antibody‐drug conjugates against tissue factor in stroma‐rich allograft models
Tissue factor (TF) is known to be overexpressed in various cancers including pancreatic cancer. The upregulation of TF expression has been observed not only in tumor cells, but also in tumor stromal cells. Because of the potential of TF as a delivery target, several studies investigated the effectiv...
Autores principales: | Tsumura, Ryo, Manabe, Shino, Takashima, Hiroki, Koga, Yoshikatsu, Yasunaga, Masahiro, Matsumura, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778651/ https://www.ncbi.nlm.nih.gov/pubmed/31348600 http://dx.doi.org/10.1111/cas.14146 |
Ejemplares similares
-
ET-05 PRECLINICAL STUDY OF AN ANTI-HUMAN TISSUE FACTOR ANTIBODY-DRUG CONJUGATE IN A MALIGNANT GLIOMA XENOGRAFT MODEL
por: Takashima, Hiroki, et al.
Publicado: (2019) -
Antitumor effect of antitissue factor antibody‐MMAE conjugate in human pancreatic tumor xenografts
por: Koga, Yoshikatsu, et al.
Publicado: (2015) -
Imaging mass spectrometry for the precise design of antibody-drug conjugates
por: Fujiwara, Yuki, et al.
Publicado: (2016) -
Development of Antibody–Drug Conjugates Using DDS and Molecular Imaging
por: Yasunaga, Masahiro, et al.
Publicado: (2017) -
Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models
por: Yamamoto, Yoshiyuki, et al.
Publicado: (2015)